Evaluating the Cardiovascular Benefits of Antidiabetic Medications


Cardiovascular disease is the primary cause of death among patients with diabetes. Accordingly, the most effective antidiabetic drug therapies not only correct metabolic dysfunction but also protect the cardiovascular system from the effects of hyperglycemia. However, not all new drugs do both. Evaluate the evidence on the cardiovascular risks and benefits of the latest drugs compared with older therapies such as metformin.

This session will be audio-recorded and offered as part of the Home-Study on Demand, included with Premium Registration or available for purchase on-site at the Education Booth.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Describe the evidence regarding the cardiac risks and benefits of antidiabetic agents. 
  2. Select antidiabetic agents to meet individual patient needs.


This activity is supported by an independent educational grant from Novo Nordisk, Inc.

Stuart Haines, PHARMD
Professor and Director, Pharmacy Professional Development
University of Mississippi School of Pharmacy
Learning Level: Level 2
Track: Clinical Patient Care and Services
Session Time Slot(s): 
Sunday, March 18
5:30 PM - 6:30 PM
Music City Center - Room 101C-D
ACPE Pharmacist: 0202-0000-18-054-L01-P
CEUs Pharmacist: 0.1
Activity Type: